Tumor-derived exosomal miR-425-5p and miR-135b-3p enhance colorectal cancer progression through immune suppression and vascular permeability promotion

doi:10.4251/wjgo.v17.i6.106161

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1052)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

477

Figures (1-5)

134

Tables (1-2)

113

Sum=754

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

237

Sum=265

Jun 15, 2025 (publication date) through Jul 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jun 15, 2025; 17(6): 106161
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.106161

Table 2 Antibodies used in flow cytometry

Antibody	Catalog number	Manufacture
THP-1 cells
Anti-CD86-FITC	557343	BD Biosciences, NJ, United States
Anti-iNOS	ab283655	Abcam, United Kingdom
Alexa Fluor^® 488	ab236553	Abcam, United Kingdom
Anti-CD163-PE	560933	BD Biosciences, NJ, United States
Anti-CD206-APC	561763	BD Biosciences, NJ, United States
CD4⁺ T cells
Anti-CD4-FITC	561005	BD Biosciences, NJ, United States
Anti-IFN-γ-PE	561056	BD Biosciences, NJ, United States
Anti-IL4-PE	554485	BD Biosciences, NJ, United States
Anti-IL17A-PE	560438	BD Biosciences, NJ, United States
Anti-CD25-FITC	560990	BD Biosciences, NJ, United States
Anti-Foxp3-PE	560082	BD Biosciences, NJ, United States
Mouse tumor cells
Anti-CD4-FITC	553046	BD Biosciences, NJ, United States
Anti-IFNγ-PE	562020	BD Biosciences, NJ, United States
Anti-IL4-PE	562044	BD Biosciences, NJ, United States
Anti-IL17A-PE	561020	BD Biosciences, NJ, United States
Anti-CD25-APC	561048	BD Biosciences, NJ, United States
Anti-Foxp3-PE	563101	BD Biosciences, NJ, United States

CD86: T-lymphocyte activation antigen CD86; iNOS: Inducible nitric oxide synthase; CD163: Scavenger receptor cysteine-rich type 1 protein M130; CD206: Macrophage mannose receptor 1; CD4: T-cell surface glycoprotein CD4; IFN-γ: Interferon gamma; IL-4: Interleukin 4; CD25: Interleukin-2 receptor subunit alpha; FoxP3: Forkhead box protein P3.

Citation: Feng CZ, Zhong SQ, Ye SW, Zheng Z, Sun H, Zhou SH. Tumor-derived exosomal miR-425-5p and miR-135b-3p enhance colorectal cancer progression through immune suppression and vascular permeability promotion. World J Gastrointest Oncol 2025; 17(6): 106161
URL: https://www.wjgnet.com/1948-5204/full/v17/i6/106161.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.106161